# Nintedanib esylate

NDC: 33342-550
Generic name: Nintedanib esylate
Labeler / Manufacturer: Macleods Pharmaceuticals Limited
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20260803

FDA application: ANDA219926

## Active ingredients

- NINTEDANIB ESYLATE: 100 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"33342-550"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=33342-550
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9925b305-c1fb-43b6-a5fd-e03f14f28e6c